Waystar Weighs Sale Amid Falling Market Value, Sources Reveal

Waystar, a prominent player in the healthcare software industry, is reportedly exploring strategic options, including a potential sale, according to insiders familiar with the situation. The company, which went public in New York two years ago, has engaged investment bank Evercore to advise on the possible transaction. The process is still in its preliminary stages, and a sale is not guaranteed, according to two sources who requested anonymity due to the confidential nature of the information.

Market Pressures and Strategic Positioning

Headquartered in Lehi, Utah, and Louisville, Kentucky, Waystar specializes in software solutions that assist hospitals and physicians in managing payment processes. The firm has strategically positioned itself as a technology company rather than a service-based business, aiming to capitalize on higher valuations typically associated with tech firms. Despite initial investor enthusiasm, which saw the company's stock price rise from $20 to a peak of $45 in 2025, Waystar has faced market challenges. Its market value has dropped to approximately $4.8 billion following a 24% decline in share price this year amid a broader downturn in the software sector.

Shareholder Dynamics and Future Prospects

Waystar's ownership structure includes significant stakes held by major investment entities: EQT, the Canada Pension Plan Investment Board (CPPIB), and BlackRock Institutional Trust Company. EQT remains the largest shareholder with a 13% stake, followed by CPPIB with 10%, and BlackRock with 8%, according to data from LSEG. Both EQT and BlackRock declined to comment on the potential sale, and CPPIB did not immediately respond to inquiries.

The company's current exploration of a sale may serve as a barometer for investor interest in the software sector, which has been under pressure from concerns about technological disruptions, including advances in artificial intelligence. Morgan Stanley analysts noted in a July report that such concerns have contributed to investor caution.

Corporate History and Recent Developments

Waystar was established in 2017 through the merger of Zirmed and Navicure, two companies focused on healthcare revenue management. The firm went public in 2024, backed by EQT, CPPIB, and Bain Capital. Despite the recent decline in its market value, Waystar continues to focus on its core mission of automating and streamlining administrative tasks within the healthcare sector.

As the company navigates its current strategic review, the outcome remains uncertain. Whether Waystar will proceed with a sale or explore other avenues to bolster its market position will depend on the evolving interests of its stakeholders and the broader market climate.